I am currently an Associate Professor in Health Economics at Imperial College Business School. By background, I am a health economist, with an expertise on: i) the design of optimal financing policies; ii) the evaluation of the impact of health policies and interventions on institutional strategies and performance; iii) decision making in the context of health.
I have joined the Imperial College Business School and the Health Care Management Group in 2008. In the past I have held academic appointments at the Centre for Health Economics and the Department of Economics and Related Studies both at the University of York.
As academic background I hold a PhD in economics from York University, a MSc in Economics and Finance from Universitat Pompeu Fabra, a Master of Arts in Economics from Université Catholique de Louvain and a first degree in economics from Universidade Católica Portuguesa.
Over the past years I have established my career in this field building a healthy track record of policy relevant publications, establishing research collaborations, successful grant applications and, leading and delivering modules on health economics and health policy. Besides research, lecturing and successful grant applications, I have been actively involved in a number of advisory, research, and executive training collaborations with international institutions in the public and corporate sectors, which have greatly enhanced my experience to apply economic insights to the analysis of health policies.
PhD in Economics, University of York, 2007
My research focuses on: i) the design of optimal financing policies; ii) the evaluation of the impact of health policies and interventions on institutional strategies and performance; iii) decision making in the context of health. My research spans across different fields, including public health, economics and policy. Understanding the interplay between these is crucial to understanding the environment in which healthcare stakeholders operate and how it shapes their decisions and strategies. My mission is to support innovative evidence-based policies and business models addressing the strategic challenges facing health care professionals and policy makers worldwide.
Current research topics include:
• The determinants of innovation in the pharmaceutical sector
• The impact of regulation and reimbursement policies on: the adoption of technology; pharmaceutical firms price and quality strategies; access to drugs; public & private healthcare expenditure
• Determinants of doctor’s prescription behavior and adherence to treatment
• The impact of drug advertising on market entry
• The determinants of health risky behavior such as smoking, drinking and obesity
• The determinants of the uptake of vaccination
• The determinants of competition and networks on the adoption and diffusion of innovation for cancer treatment
• The impact of reimbursement policies on hospitals efficiency and financial performance
Wheelock A, Parand A, Rigole B, Thomson A, Miraldo M, Vincent C, Sevdalis N.Socio-psychological factors driving adult vaccination: a qualitative study. PLoS One. 2014 Dec 9;9(12):e113503. doi: 10.1371/journal.pone.0113503
Wheelock A, Miraldo M, Parand A, Vincent C, Svedalis N (2014) Journey to vaccination: a protocol for a multinational qualitative study. BMJ Open, 2014;4:e004279 doi:10.1136/bmjopen-2013-004279
Miraldo, Marisa, Galizzi, Matteo M., Merla, Anna, Levaggi, Rosella, Schulz, Peter J., Auxilia, Francesco, Castaldi, Silvana and Gelatti, Umberto (2014) Should I pay for your risky behaviours?: evidence from London. Preventive Medicine, 66. pp. 145-158. ISSN 0091-7435
Refoios R, McGrath C, Miraldo M, et al., 2013, The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies, Pharmacoeconomics, Vol:31, ISSN:1170
Camejo RR, McGrath C, Rutten F, Miraldo M., 2013, Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD, Eur J Health Econ
Galizzi M, Miraldo M, Stravopoulou C, Desai M, Jayatunga W, Josh M, Parikh S. (2012). Who is More Likely to Use Doctor-Rating Websites, and Why? BMJ Open, 2012;2:e001493 doi:10.1136/bmjopen-2012-001493
Miraldo M, Siciliani L, Street A, (2012). Price adjustment in the hospital sector. A Reply, Journal of Health Economics, 2012, Vol:31.
Adesanya T, Gbolahan O, Ghannam O, Miraldo M, Patel B, Verma R, Wong H. (2012). Exploring the responsiveness of public and private hospitals in Lagos, Nigeria. Journal of Public Health Research. DOI: 10.4081/jphr.2012.e2
Galizzi, M, Miraldo M, (2011). The effects of hospitals' governance on optimal contracts: Bargaining vs. contracting. Journal of Health Economics, Elsevier, vol. 30(2), pages 408-424, March.
Galizzi MM, Ghislandi S, Miraldo M. Effects of Reference Pricing in Pharmaceutical Markets: a Review (2010). PharmacoEconomics, Vol.29, 2011
Miraldo M, Siciliani L, Street A, (2010) Price adjustment in the hospital sector, Journal of Health Economics, Vol:30, Pages:112-125
Street A, Sivey P, Manson A, Miraldo M, Siciliani L (2010). Are Treatment Centres treating less complex patients?, Health Policy, Volume 94, Issue 2, Pages 150-157, February 2010
Willis-Owen CA, Brust K, Alsop H, Miraldo M, Cobb JP (2009). Unicondylar knee arthroplasty in the UK National Health Service: An analysis of candidacy, outcome and cost efficacy. Knee, 2009, ISSN: 1873-5800
Mason A, Street A, Miraldo M, Siciliani L (2009). Should prospective payments be differentiated for public and private healthcare providers?, Health Economics, Policy and Law, 2009, Vol: 4, Pages: 383 - 403, ISSN: 1744-134X
Miraldo M (2009). Reference pricing versus co-payment in the pharmaceutical industry: firms' pricing strategies, Journal of Health Economics, 2009, Vol: 28, Pages: 176 – 197
Marini G, Miraldo M, Jacobs R, Goddard M (2008). Giving greater financial independence to hospitals: does it make a difference? The case of English NHS Trusts. Health Economics, 2008, Vol: 17, Pages: 751 - 775, ISSN: 1057-9230
Marini G., Miraldo M, Goddard M, Jacobs R (2007) Foundation Trusts in the NHS? Does more freedom make a difference? Health Policy Matters, Issue 13, September 2007
Prizes and Honors
2015- Network and competition effects in the diffusion of innovation in the NHS- Health Foundation-£500000-PI
2014- WECARE- Towards a Sustainable and Affordable Healthcare. EC FP7 (499690€)
2014- Cancer Pathways- Health Foundation- PI for the last year of the funding
2013- Grantham Institute funding for a studentships: The impact of climate change on health, health care utilization, healthcare costs.
2012-2015 Teaching Prize at Imperial College Business School
2008-2011 Yearly Research Prize at Imperial College Business School
2010 Academy of Finland Grant. Project: “Prescription decisions and the demand for pharmaceuticals” (468,166 €)
2009 Nuffield Foundation Social Sciences Small Grants (£12,000)
2005 9th Conference of the Portuguese Association of Health Economics, Lisbon: Awarded the Prize for the best article presented by a student
2005 Royal Economic Society Conference Grant
2004 SIEP (Italian Public Economics Association) Conference, Pavia: Awarded the Prize for the best article presented by a student in Public Economics
2004 October – April 2005 Scholarship by the Calouste Gulbenkian Foundation
2000-2004 PhD Scholarship by the Fundação para a Ciência e Tecnologia
2003 OCT 8th Conference of the Portuguese Association of Health Economics: Awarded the Prize for the best article presented by a student